Related Experiment Video
Updated: Apr 17, 2026

11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
3.0K
Red Ginseng Oil Enhances Lipid Metabolism and Liver Function in HepG2 Cells and Hypercholesterolemic Rats
Soo-Jeung Park1,2, Minhee Lee2,3, Seong-Hoo Park2
1Department of Culinary Nutrition, Woosong University, Daejeon, Republic of Korea.
Journal of Medicinal Food
|April 16, 2026
Summary
Red ginseng oil (KGC11o) effectively lowers cholesterol in cells and rats by improving lipid profiles and enhancing cholesterol excretion. This natural compound shows promise for managing hypercholesterolemia and related conditions.
Area of Science:
- Nutritional Biochemistry
- Pharmacology
- Cardiovascular Health
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular disease.
- Development of safe and effective lipid-lowering agents is crucial.
- Natural compounds are increasingly explored for metabolic health benefits.
Purpose of the Study:
- To investigate the antihypercholesterolemic effects of red ginseng oil (KGC11o).
- To evaluate KGC11o in vitro using HepG2 cells and in vivo using a rat model of hypercholesterolemia.
Main Methods:
- Supercritical fluid extraction was used to obtain KGC11o from red ginseng.
- HepG2 cells and a high-fat/high-cholesterol diet-induced rat model were employed.
- Serum and hepatic lipid profiles, liver injury markers, fecal cholesterol excretion, and gene expression were analyzed.
Main Results:
- KGC11o treatment significantly improved serum and hepatic lipid profiles in rats.
- It reduced markers of liver injury and increased fecal cholesterol excretion.
- KGC11o modulated key genes involved in cholesterol metabolism, including HMGCR, ACAT, CETP, LPL, LCAT, and CYP7A1.
Conclusions:
- KGC11o demonstrates significant antihypercholesterolemic effects.
- It acts by improving lipid profiles, enhancing cholesterol excretion, and regulating cholesterol metabolism genes.
- KGC11o is a potential safe, food-derived functional ingredient for managing hypercholesterolemia.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Atherosclerosis III: Management
613
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
